Education
About Us
Working with TipRanks
Follow Us
Shimadzu Corporation (JP:7701)
:7701
Asp-1929 Photoimmunotherapy
Squamous Cell Carcinoma Of Head And Neck, Head And Neck Cancer
Phase II
Active Not Recruiting
ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer
Dec 20, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Shimadzu Corporation (7701) have in its pipeline
7701 is currently developing the following drugs: Asp-1929 Photoimmunotherapy. These drug candidates are in various stages of clinical development as the company works toward FDA approval.